Nakagami T, Yamazaki Y, Miyamoto S, Sawa M
Department of Ophthalmology, Nihon University School of Medicine, Tokyo, Japan.
Nippon Ganka Gakkai Zasshi. 1995 Sep;99(9):1022-5.
The effective time course of a topical carbonic anhydrase inhibitor, MK-507, on intraocular pressure (IOP) was studied in 6 normal volunteers. As a baseline study, IOP was determined and aqueous protein concentration was determined by laser flare photometry every half hour for 5 hours with the instillation of a placebo. Then, an examination with the same time course was performed on the same subjects with the instillation of 1% MK-507 or oral administration of acetazolamide at a dose of 250 mg. MK-507 lowered IOP 30 minutes after the instillation, and showed a significant reduction of IOP at 1 hour. Aqueous protein concentration increased significantly 30 minutes after the MK-507 instillation. Acetazolamide lowered IOP 30 minutes after the administration, and showed a significant reduction of IOP at one hour. Aqueous protein concentration increased significantly one hour after the acetazolamide administration. Corneal thickness, anterior chamber depth, anterior chamber volume, and serum protein concentration were not significantly changed by the drug treatment. These results suggest that the inhibition of aqueous humor production causes the rapid reduction of IOP seen in the use of MK-507 as well as acetazolamide.
在6名正常志愿者中研究了局部碳酸酐酶抑制剂MK - 507对眼压(IOP)的有效时间进程。作为基线研究,在滴入安慰剂的情况下,每半小时测定一次眼压,并通过激光散射光度法测定房水蛋白浓度,持续5小时。然后,对同一受试者滴入1% MK - 507或口服250 mg剂量的乙酰唑胺,并进行相同时间进程的检查。滴入MK - 507后30分钟眼压降低,1小时时眼压显著降低。滴入MK - 507后30分钟房水蛋白浓度显著升高。服用乙酰唑胺后30分钟眼压降低,1小时时眼压显著降低。服用乙酰唑胺1小时后房水蛋白浓度显著升高。药物治疗后角膜厚度、前房深度、前房容积和血清蛋白浓度无显著变化。这些结果表明,抑制房水生成导致在使用MK - 507和乙酰唑胺时出现眼压快速降低。